(KPEL News) — Insurance companies across the country are dropping coverage for GLP-1 weight-loss medications, and Louisiana residents are losing access to drugs like Wegovy and Zepbound. State legislators approved budget funding for weight-loss coverage earlier this year, but Gov. According to GoodRx tracking, over 41 million people have no commercial insurance coverage for Wegovy as of 2026 — a 42% increase from 2025. What Coverage Remains in LouisianaFor Louisiana residents, coverage depends heavily on your insurance source:State Employees and Teachers: No coverage for weight loss, but GLP-1s are covered for Type 2 diabetes treatment. Commercial Insurance: Coverage varies by plan, but Louisiana residents with employer-sponsored insurance are subject to the same nationwide restrictions.